FGF2 and cardiac hypertrophy: Accumulation of fibroblast growth factor 2 (FGF-2) has been shown to exacerbate cardiac hypertrophy [24], and we demonstrated that DOX treatment increased the expression of FGF-2 (Figure 3A,B).